MUMSS
AGN

Mitsubishi UFJ Morgan Stanley Securities’s Allergan Inc AGN Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-260
Closed -$32K – 312
2014
Q1 		$32K Buy
260
+10
+4% +$1.22K 0.09% 92
2013
Q4 		$28K Buy
250
+180
+257% +$17.2K 0.05% 144
2013
Q3 		$6K Sell
70
-300
-81% -$26.9K 0.01% 238
2013
Q2 		$31K Buy
+370
New +$38.4K 0.1% 125

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mitsubishi UFJ Morgan Stanley Securities's AGN Position: Q2 2014 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 260 shares — an estimated $32K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $32K in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 260 Allergan Inc shares in Q2 2014, an estimated $32K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Allergan Inc position peaked at $32K in Q1 2014.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2014, filed 4 Aug 2014.